Form 4 Filing for Achieve Life Sciences, Inc.

This filing details a Form 4 submission for Achieve Life Sciences, Inc. (ACHV), concerning transactions by director Martin Christopher Nathan. On July 27, 2026, Nathan acquired 25,000 stock options with a right to buy common stock, exercisable at $6.18 per share, expiring in 2036. These options vest fully on July 27, 2027, or prior to the 2027 annual meeting, contingent on continued service. Additionally, 16,700 Restricted Stock Units (RSUs) were acquired, each representing a contingent right to one share of common stock. The RSUs also vest fully on July 27, 2027, or prior to the 2027 annual meeting, subject to the reporting person's continued service. Both transactions are reported as direct ownership acquisitions.